The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 112: 1867-1872.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, R. A.
Right arrow Articles by Feldman, J. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fox, R. A.
Right arrow Articles by Feldman, J. D.

Macrophage Receptors for Migration Inhibitory Factor (MIF), Migration Stimulatory Factor (MSF), and Agglutinating Factor1

Roy A. Fox2, Douglas S. Gregory and Joseph D. Feldman

From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037

Abstract

The action of macrophage migration inhibitory factor in fetal calf serum (FCS-MIF) was inhibited by l-fucose and by blood group substances and bovine submaxillary mucin, both of which contain l-fucose. FCS-MIF agglutinated human erythrocytes and guinea pig peritoneal exudate macrophages. Agglutination of these cell types was inhibited by l-fucose and N-acetyl-d-galactosamine. Human type O erythrocytes removed MIF from FCS. Supernatants of antigen stimulated guinea pig lymphocytes, containing MIF, agglutinated guinea pig peritoneal exudate macrophages which could be inhibited by l-fucose and N-acetyl-d-galactosamine; and human type A erythrocytes which could be inhibited by N-acetyl-d-galactosamine. A macrophage migration stimulatory factor in fetal calf serum (FCS-MIF) was inhibited by N-acetyl-d-galactosamine. These observations suggest that macrophages and erythrocytes have distinct membrane receptors for MIF and MSF and that these receptors contain monosaccharides.

Footnotes

1 This is Publication 783 from the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037. The work was supported by United States Public Health Service Grant AI-07007 and Atomic Energy Commission Contract AT(04-3)-779.

2 During part of these studies Roy A. Fox was supported by a Medical Research Council (United Kingdom) Travelling Scholarship. Present address: Dalhousie University, Halifax, Nova Scotia, Canada.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.